| MVCAX | VASVX | MVCAX / VASVX | |
| Total Expense Ratio | 0.97 | 0.34 | 285% |
| Annual Report Gross Expense Ratio | 0.98 | 0.34 | 288% |
| Fund Existence | 25 years | 31 years | - |
| Gain YTD | 17.060 | 18.363 | 93% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.6B | 6.98B | 252% |
| Annual Yield % from dividends | 1.09 | 1.69 | 65% |
| Returns for 1 year | 12.11 | 8.85 | 137% |
| Returns for 3 years | 28.48 | 13.21 | 216% |
| Returns for 5 years | 20.09 | 2.00 | 1,005% |
| Returns for 10 years | 85.86 | 13.84 | 620% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RGCIX | 10.49 | N/A | N/A |
| Russell Inv Global Infrastructure C | |||
| MOGLX | 11.87 | -0.06 | -0.50% |
| Gabelli Media Mogul | |||
| WLCVX | 25.73 | -0.16 | -0.62% |
| Wilshire Large Company Value Instl | |||
| GLCUX | 36.43 | -0.26 | -0.71% |
| Goldman Sachs Large Cap Gr Insghts R6 | |||
| JFNNX | 92.33 | -1.78 | -1.89% |
| Janus Henderson Global Life Sciences N | |||